Michele Marzola

Michele Marzola is an accomplished entrepreneur and investor with extensive experience in the medical technology and biotechnology sectors. Currently serving as the Director and Lead Investor at Nanoligent, PEP-Therapy, Sooma Medical, WATGRID, REJOINT, and as Co-Founder and CEO of Interceptin srl, Michele is focused on innovative solutions for cancer treatment, mental health, and orthopedic surgery. Additionally, as the Founder and CEO of Surgica Robotica and Chairman of XSurgical Inc., Michele is developing advanced robotic systems for microsurgery. With a strong educational background, including an MBA from Columbia Graduate School of Business and a doctorate in Mechanical Engineering from the University of Bologna, Michele also actively participates as an investor with IAG - Italian Angels for Growth.